Connecting you to content on EBSCOhost

Works matching IS 10109609 AND DT 2012 AND VI 26 AND IP 2

Results: 45

1

International Nonproprietary Names for Pharmaceutical Substances (INN)

Published in:: 2012
Publication type:: Journal Article

2

ATC/DDD Classification (Final)

Published in:: 2012
Publication type:: Journal Article

3

ATC/DDD Classification (Temporary)

Published in:: 2012
Publication type:: Journal Article

4

International Nonproprietary Names for Pharmaceutical Substances (INN).

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 157
Publication type:: Article

5

Sulfamethoxazoli et trimethoprimi solutionum peroralum Sulfamethoxazole and trimethoprim oral suspension.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 152
Publication type:: Article

6

Sulfamethoxazoli et trimethoprimi infusio intraveno Sulfamethoxazole and trimethoprim intravenous infusion.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 147
Publication type:: Article

7

Fluconazoli injectio Fluconazole injection.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 144
Publication type:: Article

8

Fluconazoli compressi Fluconazole capsules.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 141
Publication type:: Article

9

Fluconazoli Fluconazole.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 136
Publication type:: Article

10

Mefloquini hydrochloridum Mefloquine hydrochloride.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 132
Publication type:: Article

11

Levonorgestrel and ethinylestradiol tablets.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 128
Publication type:: Article

12

Persisting pain in children: treatment guidelines.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 127
Publication type:: Article

13

Guide on estimating pain medication requirements.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 127
Publication type:: Article

14

Interagency emergency health kit 2011.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 126
Publication type:: Article

15

International meeting of world pharmacopoeias.

Published in:: 2012
Publication type:: Proceeding

16

Safety of medicines in sub-Saharan Africa.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 125
Publication type:: Article

17

Evolving threat of antimicrobial resistance.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 125
Publication type:: Article

18

ATC/DDD Classification (Final).

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 122
Publication type:: Article

19

ATC/DDD Classification (Temporary).

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 119
Publication type:: Article

20

Lapatinib: withdrawal of marketing authorization application.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 118
Publication type:: Article

21

Megestrol: withdrawal of marketing authorization application.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 118
Publication type:: Article

22

Rivastigmine: withdrawal of marketing authorization application.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 118
Publication type:: Article

23

Capsaicin: withdrawal of marketing authorization application.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 117
Publication type:: Article

24

Florbetapir: approved to estimate brain amyloid plaque content.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 117
Publication type:: Article

25

Pazopanib: approved for soft tissue sarcoma.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 117
Publication type:: Article

26

Levofloxacin approved for plague.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 116
Publication type:: Article

27

Pixantrone: conditional approval for non-Hodgkin B-cell lymphoma.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 116
Publication type:: Article

28

Aprotinin: suspension lifted.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 116
Publication type:: Article

29

Pyronaridine and artesunate: new anti-malarial approved.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 115
Publication type:: Article

30

Commercially confidential information and personal data.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 115
Publication type:: Article

31

Empowering patient ADR reporting.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 114
Publication type:: Article

32

Escitalopram: abnormal heart rhythm.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 113
Publication type:: Article

33

Belimumab: hypersensitivity and infusion reactions.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 113
Publication type:: Article

34

Antithrombotic medicines and bleeding.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 113
Publication type:: Article

35

Lenalidomide: increased malignancies.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 112
Publication type:: Article

36

Finasteride and dutasteride: prostate cancer.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 112
Publication type:: Article

37

Vandetanib: risk of fatal outcome.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 112
Publication type:: Article

38

Domperidone maleate: ventricular arrhythmias and cardiac death.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 111
Publication type:: Article

39

Minocycline: lupus erythematosus and autoimmune hepatitis.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 110
Publication type:: Article

40

Benzocaine: new risk statements.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 110
Publication type:: Article

41

Pioglitazone: bladder cancer.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 110
Publication type:: Article

42

Fingolimod: new safety advice.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 109
Publication type:: Article

43

Strontium ranelate: new contraindications and revised warnings.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 109
Publication type:: Article

44

Tolvaptan: risk of serious neurological events.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 109
Publication type:: Article

45

WHO Prequalification of Medicines Programme.

Published in:: WHO Drug Information, 2012, v. 26, n. 2, p. 99
Publication type:: Article